Nurix Therapeutics (NRIX) Net Equity Issued and Repurchased (2019 - 2026)
Nurix Therapeutics (NRIX) posted Net Equity Issued and Repurchased of $18 million for fiscal Q1 2026 (quarter ended Feb 28, 2026), compared with $1.25 million a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Net Equity Issued and Repurchased came in at $2.23 million, down 99.2% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -60.0% (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Net Equity Issued and Repurchased was $289.76 million in FY2024, $2.23 million in FY2023 (-88.5%), $19.4 million in FY2022 (-87.1%) and $150.16 million in FY2021 (-31.2%).
- The fiscal Q1 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since fiscal Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 18.00 Mn |
| Aug 31, 2025 | 977,000.00 |
| Feb 28, 2025 | 1.25 Mn |
| Nov 30, 2024 | 199.07 Mn |
| Feb 29, 2024 | 1.27 Mn |
| Aug 31, 2023 | 776,000.00 |
| Feb 28, 2023 | 1.45 Mn |
| Nov 30, 2022 | -75.54 Mn |
| Aug 31, 2022 | 93.88 Mn |
| Feb 28, 2022 | 1.06 Mn |
| May 31, 2021 | 149.11 Mn |
| Feb 28, 2021 | 1.04 Mn |
| Nov 30, 2020 | -1.15 Mn |
| Aug 31, 2020 | 99.39 Mn |
| May 31, 2020 | 119.87 Mn |
| Feb 29, 2020 | 47,000.00 |
| Nov 30, 2019 | 80,000.00 |
API Access
Nurix Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();